John Michael Maisch
John Michael Maisch (1831–1893) was a prominent figure in the field of pharmacy in the United States during the 19th century. His contributions to the profession, particularly in the areas of pharmaceutical education and legislation, have left a lasting impact. Born in Germany, Maisch immigrated to the United States where he quickly became involved in the pharmacy sector. He is best known for his role in the founding of the American Pharmaceutical Association (APA), now known as the American Pharmacists Association, in 1852. This organization was pivotal in setting standards for the profession and advocating for the role of the pharmacist in healthcare. Throughout his career, Maisch held several important positions, including that of Professor of Materia Medica at the Philadelphia College of Pharmacy, one of the first pharmacy schools in the United States. His work in education was instrumental in shaping the curriculum and standards for pharmacy education nationwide. Maisch was also a prolific writer, contributing numerous articles and books on pharmacognosy, pharmacy practice, and drug legislation. His efforts in these areas were crucial in the development of pharmacy as a recognized profession in the United States. In addition to his educational and professional contributions, Maisch played a significant role in the development of pharmaceutical legislation. He was a strong advocate for the regulation of drugs and played a key role in the drafting and passage of the first comprehensive drug legislation in the United States, which laid the groundwork for modern pharmaceutical law. John Michael Maisch's legacy in pharmacy is marked by his commitment to education, professional standards, and legislation. His work helped to establish pharmacy as a vital part of the healthcare system in the United States.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD